These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5755631)

  • 1. [Treatment of the myasthenic syndrome with Mestinon retard].
    Mittelbach F; Pongratz D
    Munch Med Wochenschr; 1968 May; 110(22):1375-80. PubMed ID: 5755631
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems].
    Chesni Y
    Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous infusion of pyridostigmine for myasthenic crisis.
    Nicholson J; Grant IS
    Crit Care Med; 1994 May; 22(5):895-6. PubMed ID: 8181302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conservative treatment of pseudoparalytic myasthenia gravis].
    Vieth J
    Med Welt; 1971 Sep; 38():1496. PubMed ID: 5097679
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapetic measures in myasthenia gravis].
    Cavaciuti P; Gatti E
    Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of polstigmine on the status of the respiratory muscles and pulmonary function in patients with myasthenia gravis].
    Radwan L; Strugalska MH; Koziorowski A
    Pneumonol Pol; 1987; 55(11-12):499-503. PubMed ID: 3444736
    [No Abstract]   [Full Text] [Related]  

  • 8. Recovery from myasthenic crisis after use of IVIG therapy.
    Jain K; Passi GR; Rajguru M; Athle S; Gandhi DM
    Indian Pediatr; 1998 Sep; 35(9):901-3. PubMed ID: 10216601
    [No Abstract]   [Full Text] [Related]  

  • 9. Myasthenia gravis and preeclampsia.
    Cohen BA; London RS; Goldstein PJ
    Obstet Gynecol; 1976 Jul; 48(1 Suppl):35S-37S. PubMed ID: 940634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis.
    Murray KB
    Kans Med; 1990 Jun; 91(6):181-3. PubMed ID: 2398638
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of myasthenia gravis with germine diacetate.
    Flacke W; Caviness VS; Samaha FG
    N Engl J Med; 1966 Dec; 275(22):1207-14. PubMed ID: 5921854
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal clearance of pyridostigmine in patients with myasthenia gravis.
    Chan K; Calvey TN
    Eur Neurol; 1977; 16(1-6):69-72. PubMed ID: 615720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A curable muscular disease].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1976 Jan; 120(5):181-4. PubMed ID: 1250450
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of myasthenia gravis pseudoparalytica. Analysis of 60 personal cases and study of the literature].
    Mumenthaler M; Ltschg J; Rossi L
    Clin Ter; 1976 Sep; 78(5):405-20. PubMed ID: 188592
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenic crisis--your assessment counts.
    Hickey JV
    RN; 1991 May; 54(5):54-9. PubMed ID: 2028194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of myasthenia gravis].
    Janda A; Brandstetter A
    Dtsch Med Wochenschr; 1986 Jul; 111(27):1081-2. PubMed ID: 3720565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis accompanied with hypokalemic periodic paralysis.
    Sawanyawisuth K; Tiamkao S; Pratipanawatr T
    J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pro-arrhythmia effect of pyridostigmine. Apropos of a case].
    Leenhardt A; Thomas O; Haouala H; Benaïm R; Maison-Blanche P; Cauchemez B; Haguenau M; Coumel P; Slama R
    Arch Mal Coeur Vaiss; 1992 Dec; 85(12):1853-6. PubMed ID: 1306628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.